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The systematic study of cellular reactions to purified chemical
fractions of the tubercle bacillus was first demonstrated by Sabin and
her co-workers.'5 16, 17, 18 These chemically purified derivatives were
prepared by Anderson of Yale. The above studies have contributed
greatly to our knowledge of the pathogenesis of tuberculosis. Through-
out all of the above work, however, no one specific factor was isolated
towhich theso-called "virulence" ofthe bacillus can be attributed. There
has likewise as yet been no chemical evidence forthcoming which has
shed any light upon the chemical differentiation between virulent and
avirulent strains. Sabin et al. have shown, however, that the lipoid sub-
stances have exceeded all others in their ability to act as stimulants
and maturation factors in the life cycle of the epithelioid cells of the
host. This cellular phenomenon was demonstrated repeatedly with the
phosphatide fraction of the bacillus. Later it was found that phthioic
acid, a new fatty acid isolated by Anderson from the phosphatide frac-
tion, was by itself capable of stimulating monocytes and epithelioid
cells resultingin the formation of thetuberculous tissue. Although much
work has been done with the phosphatide fraction, there has been no
evidence assigning the latter to any specific role in the immunological
mechanism ofthedisease. A greatdeal of investigation has been devoted
to the antigenic properties of the lipoids, including fats, compound
lipoids such as the phosphatides,1 4 5 cerebrosides, and the derived
lipoids; also those substances obtained from the simple and compound
lipoids by hydrolysis, e. g., sterols and fatty acids. Recently, Gerstl
and his co-workers,6 using mycolic acids derived from the waxes of
human, bovine, and avian tubercle bacilli, and from the leprosy
bacillus, demonstrated that these hydroxy acids are responsible for
the presence and persistence of the necrotic lesions induced by the above
bacilli, but are not related to the elective pathogenicity of these different
strains. The latter observations would tend to corroborate the findings
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of other workers' that lipoid substances stripped of all bacillary debris,
protein, carbohydrates, etc. are not related to virulence or native re-
sistance. In combination with other chemical components, however,
whether within the living organism or in isolated form from the latter,
thesubjectof lipoid specificity becomes one which deserves much further
study. Some light might be shed on the nature of lipoid complexes by
techniques which would permit isolation in pure condition of the
various lipoids obtained by alcoholic or ether extractions of bacteria and
tissues. Such complexes as the 0 and Vi antigens from the typhoid
bacillus, the Forssmann body, the human blood groups, might serve as
logical starting points. The successful development of such techniques
might well lead to the isolation of a "P" factor, as discussed by Middle-
brook,'3 namely, "that factor or component within the organism having
the capacity for causing progressive tuberculosis by bacterial multiplica-
tion in vivo."
It was previously shown by one of the authors9 that a protein-free
polysaccharide fraction from the human strain bacillus H37, elicited
certain cellular and immunological responses, when given repeatedly
and in increasing doses, in animals and human beings. In due course of
these studies observations were made with other carbohydrate protein-
free fractions isolated from the tubercle germ mass; some of these frac-
tions contained lipoid substances in varying amounts. Some of the latter
were tested in small groups (6 to 12) of animals using an equal number
for controls. It was found that the lipoid-containing fractions conferred
amuchgreaterdegreeofimmunity againstsubsequentinfection than did
the carbohydrate fractions free from lipoidal material. Even though
the number of animals used in these preliminary trials was small, we
felt the degree of protection conferred warranted further study. Conse-
quently a lipoid-carbohydrate complex was isolated (as described be-
low) and used in the present laboratory and clinical investigations.
Materials and methods
The complex was isolated from alcohol-ether extracts of virulent H37
bacilli. The bacilli were grown on Long's synthetic medium for a period of 6
to 8 weeks. The cultures were then filtered through Buchner funnels and
placed in a mixture of equal parts of alcohol and ether. This mixture was
allowed to stand at room temperature with intermittent shaking for a two-week
period. The bacilli were again filtered through Buchner funnels and the filtrate
saved. The filtrate was passed through a Berkefeld filter and placed over a
steam-bath and allowed to evaporate until a sticky residue remained. The
residue was extracted with ether until no further amber color appeared in the
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extract. To the pooled ether washings was added 95 per cent alcohol until no
further precipitation occurred. The precipitate was separated by centrifugation
and when dried formed a thin opalescent scale. In a mortar this scale was
ground to a powder from which aliquots were taken to make up the desired
aqueous concentrations.
The product when ready for animal testing was free from protein and
protein-nitrogen according to the Biuret, ninhydrin, and sodium fusion tests.
It gave an intense Molisch reaction and did not show reducing sugars until
hydrolyzed with 5 per cent sulfuric acid. It formed typical glucosazones with
phenylhydrazine hydrochloride. The complex was slowly soluble in water and
formed an opalescent solution. Further chemical study of the complex is now
being undertaken.
Toxicity
The tests for toxicity were carried out in tuberculous and in non-
tuberculous guinea-pigs and rabbits. It was found that tuberculous
guinea-pigs succumbed to 5 mg. given intraperitoneally within 48
hours. Non-tuberculous animals tolerated the above amount, but died
at the end of 72 hours from 20 mg. given by the same route. Normal
rabbits tolerated 3 mg. intravenously without manifesting any untoward
effects. Repeated intravenous and subcutaneous injectionsofthe complex
were given to rabbits and guinea-pigs, respectively, to rule out the pos-
sibility of allergy and anaphylaxis. The rabbits received a total of 50
mg. intravenously. They were then permitted to go untreated for two
weeks, at the end of which time they were given 3 mg. intravenously.
There was no sign of any symptoms (rise in temperature, in breathing,
etc.) in any of the rabbits or guinea-pigs so tested. Subcutaneous and
intracutaneous injections were also made with the complex. It was
found that 1 mg. given intracutaneously produced an induration with
erythema in both the normal and the tuberculous guinea-pig. When
this amount was increased to 4 mg. abscess formation occurred in
the tuberculous animal within the following three or four days.
Post-mortem examinations performed on animals (tuberculous and
non-tuberculous) that succumbed to intraperitoneal injections of the
complex, revealed no gross pathology in any of the organs other
than a peritonitis. No microscopic study was made on the peritoneal
tissue of these animals. Temperatures (rectal) were seen to rise from
1 to 2 degrees in both tuberculous and non-tuberculous animals follow-
ing intraperitoneal injections of sub-lethal doses of the complex, but
returned to the original level after 24 hours. Temperatures rose from
2 to 4 degrees following advent of lethal doses of the latter. There was
no fluid accompanying the peritonitis in any of the autopsied animals.
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Experimental
It was decided to determine first the prophylactic effect of this
fraction on 24 animals; 12 of these were treated and 12 were used as
controls. The number of animals and thevariety ofconditions have been
limited due to the small yield of the fraction. The weight of the animals
varied between 350 and 450 gm. All animals were weighed previous to
injections of any kind. All of the animals were skin-tested with 0.5
percentO.T. before treatmentor injection, and no positive reactors were
seen. The 12 immunized animals received a total of 14 mg. of the
fraction subcutaneously during an eight-week period. The injections
were given on alternatedays three times a week. A rise of 1 to 2 degrees
in temperature was observed following each immunizing dose of the
fraction during the entire period of immunization. We have as yet no
experimental evidence to accountfor this phenomenon, since all animals
wereskin-testnegative, andwere apparently healthy in all other respects.
Aperiod of five days was allowed to elapse at the end of the three-week
immunization period at which time all 24 animals were given an
infecting dose of 0.01 mg. of virulent H37 tubercle bacilli in the right
groin. No further treatment was given to the immunized animals after
the infecting dose. The results of the above experiment are recorded
in table 1.
TABLE 1
Controls Treated
Duration Duratio.
of experi- of experi-
Cause of Degree of ment. Cause of Degree of ment.
No. death tuberculosis Days No. death tuberculosis Days
1 Tuberculosis + + + 40 1 Tuberculosis + + + 32
2 Tuberculosis + + + 46 2 Tuberculosis + + + 157
3 Tuberculosis + + 80 3 Tuberculosis + + + 185
4 Tuberculosis + + + 145 4 Sacrificed + 297
5 Tuberculosis + + + 178 5 Sacrificed + 297
6 Tuberculosis + + + 178 6 Sacrificed + + 297
7 Tuberculosis + + 186 7 Sacrificed + 297
8 Tuberculosis + + + 186 8 Sacrificed + + 297
9 Tuberculosis + + + 190 9 Sacrificed + 297
10 Tuberculosis + + + 198 10 Sacrificed + + 297
11 Tuberculosis + 198 11 Sacrificed + + 297
12 Sacrificed + 297 12 Sacrificed + 297
Ave. no. days-246 Ave. no. days-160
Degree of tuberculosis:
+ + + General disease
+ + Local site and liver and spleen
+ Local site and lymph nodes
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It will be seen in table 1 that all of the control animals died of
tuberculosis with one exception. Sections of the liver, spleen, and lung
of this animal were studied microscopically and no evidence of disease
was seen in any of the above-mentioned organs. The inguinal and
tracheo-bronchial lymph nodes, however, were enlarged and contained
caseous cores. Smears made from the caseous material of these glands
showed acid-fast bacilli.
It is of interest to note that the animal which was the largest in
the control group at the beginning of the experiment (455 gm.) at
the time of death weighed 585 gm. Of the treated animals that died
of tuberculosis the gross and microscopic pathology was typical in
all respects. In the immunized animals where the extent of disease was
++, sections made for microscopic study of the infected organs showed
a healed type of disease; that is, the tubercles seen in these sections were
without central necrosis and were accompanied by a considerable
amount of fibrosis. A few scattered acid-fast bacilli were demonstrable,
however, in the lesions of these organs. All of the treated animals which
were sacrificed had shown a progressive gain in weight throughout the
experiment. It would seem from the microscopic sections studied that
the resistance in the treated animals (with three exceptions) had been
increased to such a degree that the establishment of generalized disease
was retarded. We are unable, as yet, to account for the extent of disease
seen to develop in the three treated animals which succumbed to the
disease.
Followingthe above experimentitwasdecided to testthetherapeutic
properties of the complex, as well as to repeat the prophylactic ex-
periment, and to use a larger number of animals. For this purpose 58
animals were selected, 20 for prophylaxis, 20 for therapeutic treatment,
and 18 as controls. The infecting dose was 0.01 mg. of virulent strain
H37 given subcutaneously in the right groin. An interval of 30 days
was allowed to elapse before treatment with the complex was started on
any of the animals. The amount of complex administered, the route of
injections, and the period of treatment were the same for this pro-
phylactic group as in the first experiment. The therapeutic group was
treated bi-weekly for a six-week period, during which time these
animals received the same amount of the complex (6 mg.) as the pro-
phylactic group. No further treatment of any kind was given to this
group. The results are presented in table 2.
Unfortunately an epidemic of spontaneous pneumonia, type 19,
broke out in the animal colony forcing us to sacrifice all of the animals
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in this experiment at the end of the third month. It will be noted from
table 2, however, that there is a significant difference in the degree of
tuberculosis present in the treated and in the control animals. A differ-
ence is also seen in theprophylactic and therapeutic groups. The contrast
in the latter instance may be due to the toxicity of the complex (rise in
temperature in non-tubercular animals) in addition to the superimposed
pneumonic infection. Microscopic sections made from the organs of
the sacrificed animals, in both the prophylactic and therapeutic groups
where the tuberculous process was not complicated by pneumonia,
were similar to those observed in the first experiment. The degree of
fibrosis was not so great as that seen in the first experiment, however.
Even though we were forced to terminate this experiment prematurely,
we feel justified in concluding that the trend of this experiment par-
alleled that of the first. The experiment is now being repeated.
Since there was a considerable degree of protection conferred on
the animals in the above experiment, we were interested in determining
if possible the nature of the mechanism elicited by injections of the
complex in the animal body. For this purpose two avenues of approach
were considered, namely, the serological and hematological. Serologi-
cally, tests for the presence of precipitin-type antibody were made with
a variety of sera. The results of the tests appear in table 3.
TABLE 3
No. Sera Results
12 Non-T.B. 8 (+) 4 (-)
persons__
62 T.B.patients 62_____ before treatment 32 () 30(-
T.B. Patients 62 after treatment 46 (+) 16 ()
16 Normal rabbits 16 (+)
16 Complex-immune rabbits 16 (+)
The technique employed in the above tests consisted in overlaying
the serum with an aqueous suspension of the complex. A test was con-
sidered positive when after four or five minutes standing at room tem-
perature a precipitate (white ring) developed at the interface of the
serum and complex. Any precipitate forming after 15 minutes was
not taken into consideration. The precipitate which formed usually fell
to the bottom of the tube after standing at room temperature for 12
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hours. These tests were so sharply defined that only two symbols (+)
and (-) were used to designate positive or negative results. The
concentration of the complex in the above tests was the same as that
used for injection purposes (1 mg. per cc.). The concentration of the
serum was likewise unaltered. In some instances, however, where nega-
tive tests were obtained variations in both serum and complex con-
centrations were made, but without producing any effect upon the
negativity of the test. The fact that all the sera from normal and from
immunized rabbits gave positive tests cannot be explained at this
time. We feel that the results of the serological tests are too inconsistent
to permit association with any specific humoral (antibody) defense
mechanism. Experiments are presently under way, however, which we
feel will yield more conclusive evidence as to the nature of the sero-
logical reactivity of this carbohydrate-lipid complex.
The possibility that some one of the cellular elements of the blood
might reflect the mechanism of protection stimulated by injections of
the complex was also considered. For this purpose it was decided
to follow the trend of the differential blood picture for two weeks pre-
vious to any injection of the complex in both the tuberculous patients
and animals. The counts were taken at 10 A. M. each day during the
two-week period and were continued for one month after injection of
the complex was started in both the human and animal groups. The
counts were made 24 hours after each injection of the complex. It was
found thatthe fluctuations in all ofthe cellular elements after each injec-
tion were very similar to those seen in the series of counts taken before
injections were started. Wright's stain was used throughout and 100
cells were counted in each instance.
Discussion oflaboratoryresults
One can well be led into an unending and inconclusive discussion
when attempting to isolate any specific factor in the chemotherapy and
serology of tuberculosis. The subject of enzyme specificity in tuber-
culosis has recently been given support by the work of Gerstl and his
co-workers5 atYale. These workers feel that the splitting of the tubercle
phosphatide by enzymes extracted from the lung, liver, and kidney
represents a cellular mechanism vitally concerned with resistance to
tuberculosis. In the present paper it is seen that no one specific factor
was isolated which could be intimately associated with the resistance ob-
served in the treated animals. In view of these observations one can
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logicallylook to apossible intracellular mechanism. This mechanism can
-be seen in the light of two possibilities (a) an enzyme system,5 and (b)
the intracellular antibody phenomenon as first suggested by Man-
waring'1' 12 and Chase.3 The latter rendered guinea-pigs hypersensitive
to tuberculin and subcutaneous injection of killed tubercle bacilli.
Exudates were then induced in the peritoneal cavities by intraperitoneal
injections of liquid petrolatum. After 48 hours the peritoneal cavities
were washed out with heparinized Tyrode solution containing 10 per
cent normal guinea-pig serum. The exudate thus obtained consisted
mostly of large mononuclear cells. These cells were then immediately
injected (intraperitoneally or intravenously) into normal albino guinea-
pigs. From 20 to 36 hours following intravenous injection, tuberculin
hypersensitivity became established in the skin of the recipient. The
degree of sensitivity in the recipient was correlated with the volume of
peritoneal cells and the degree of sensitivity of the tuberculous donor.
Regardless of which of the two systems is involved in the resistance
mechanism in tuberculosis, one or possibly both may function in the
effort of the fixed or the wandering cell to retard the multiplication of
tubercle bacilli or greatly to limit the damaging effect of a specific
component in the tubercle bacillus to which virulence might be attrib-
uted. We know also from the work of Lurie"0 that the activity of the
phagocyte from immunized (tuberculous) animals is far greater than
that seen in the phagocyte of the normal animal. This observation was
made by.Kolmer.8 Sabin et al.15 16, 17 have repeatedly demonstrated the
reactionofcells (fixed andwandering) to injections of lipoid derivatives
from tubercle bacilli. In no instance during their studies, however, did
these workers ascribe any immunological specificity to any of the
derivatives or the cellular elements reacting to injections of the former.
Pinner,'4 on the other hand, working with a highly purified phosphatide
fraction prepared by Anderson, has found that this fraction reacts in
vitro with the serum of tuberculous patients and animals in precipitin
and complement fixation tests and is also capable of stimulating specific
antibody production in animals. The latter work likewise confirms the
earlier work of Boquet and Negre,2 who used a less purified preparation
of the phosphatide. From our own observations with the complex
mentioned here the humoral (antibody) factors as well as the fluctua-
tions seen in the cellular elements following injections of the complex
in both man and animals could not be correlated with either clinical
improvement or decline.
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Due to the absence of any known specific factor and until further
experiments now under consideration are completed, we feel justified in
believingthatsome ofthebeneficial results seen in bothman and animals
might possibly be due to the intracellular mechanism mentioned above.
Clinicalapplication
The clinical use of the products of the tubercle bacillus began with
Koch and his tuberculin O.T. The killed whole organism, its aqueous
extract or emulsion together with the many other derivatives that have
been used, have all contained the protein of the bacillus as a contami-
nating and confusing factor.
While a vast amount of work has been done in the field of protein
sensitization, little has been recorded of the clinical results obtained
with lipid or polysaccharide fractions, either alone or combined. The
production of tubercle and stimulation of the monocyte and fibroblast
with tuberculo-lipid and polysaccharide'5 has been clearly demonstrated
experimentally. The action of the polysaccharide as a hapten makes it
of some importance in humoral activity.
With the background of experimental work, there is sufficient
justification for the therapeutic use of these fractions of the tubercle
bacilli either alone or in combination. The low toxicity of these
derivatives, as contrasted with tuberculo-protein, permits of considerable
freedom in their use.
Even though bacteriolytic or bacteriostatic action may be negligible,
the lipo-polysaccharide suspension may offer some aid to the body con-
tending with a chronic destructive process. Furthermore, evidence is
slowly accumulating that the intracellular (alkaline and acid phos-
phatide) enzyme systems of the lung and liver actively respond to the
parenteral use of this combination. The latter work is presently going on
in our laboratory.
Our clinical study has been under way for more than two years.
Such reports as are made are based upon cases where recovery has taken
place and appears likely to be permanent and upon others where
steady sustained progress justifies optimism as to the final outcome.
Pulmonarytuberculosis
Only pulmonary tuberculosis has been under treatment, with
secondary infections in the bronchi in one case and with typical tuber-
cular laryngitis in two others. All of the cases selected fall into one
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group; that is, unfavorable or even hopeless. As subdivisions there are
those classed as unstable in the young adult; those with postoperative
spread; the old fibroid; and the fibro-cavernous.
It is therefore apparent that the therapeutic test of the lipo-
polysaccharide has been a rigid one, with little prospect, even at the
outset, of a high percentage of favorable results.
In 10 of a group of 14 cases, chosen because of their marked in-
stability, the results have been favorable. All of this number had
previously had the benefit of routine sanatorium treatment. The
pulmonary process had been temporarily arrested only to show renewed
activity under normal living conditions. In half of this number this had
occurred more than once. At the present time all 10 cases are well
arrested and serial x-ray films denote well-marked fibrosis. Some have
been working for from six months to one year. In such patients where
routine treatment has failed to give lasting results, the possibilities
attendant upon the use of biological products should be thoroughly
explored.
The four remaining patients, suffering from extensive, rapidly ad-
vancing disease, failed to respond to treatment and no check upon the
progressoftheinfectionwasnoted.
A series of 10 cases in which an active lesion developed or increased
in extent during treatment with pneumothorax or subsequent to
thoracoplasty or pneumonectomy, have been given a course of inocula-
tions for a period of three to five months.
To appraise the value of the fraction in these patients is difficult,
since retrogression occurs from the effects of surgery alone. A dis-
tinctively favorable impression has been gained, however, based partly
on the development of better appetite, increased sense of well-being,
consistent gain in weight, as well as x-ray evidence of retrogression of
exudative lesions in the contralateral lung.
A third section of our series has consisted of 13 bilateral or
advanced fibro-cavernous cases. Of these, most had long-standing dis-
ease and more than one cavity. A preliminary period of sanatorium
treatment, in all but one case, of from six months to five years gave
a control background. No rapid change in the x-ray picture could be
expected, but as the patient gradually built up increased tolerance to
the lipo-polysaccharide, the reaction of the pulmonary tissue was notice-
able and progressive. In three cases in which the excavated area was
larger than 6 cm. in diameter, uniform narrowing proceeded for several
months but massive hemorrhage abruptly terminated the observations.
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Hinshaw etal.7 speakofno-changes noted in the heavy-walled cavity
with the use of streptomycin. Some of our most striking results have
been in this type of disease. Of a total of 13 patients, cavity closure has
occurred in five; in five more there is every indication that this will
shortly occur; the other three died of hemorrhage. Coincident with im-
proved x-ray changes, there has been a gradual reduction in sputum and
a conversion of positive tests to negative ones. Gastric analysis in those
with complete cavity closure has been found negative.
Tuberculosis oflarynxandbronchi
Typical visual tuberculous lesions of the larynx and one of extensive
disease of the bronchi have been treated in patients with pulmonary
disease. Two cases of laryngeal ulceration have healed without local
treatment, and the structures about the chords have resumed a normal
appearance. One patient with tuberculous granulations nearly filling the
bronchi has healed with cicatrization and the complete relief of dyspnea
and wheezing.
Fibroidtuberculosis
Of the total of 51 cases that have been inoculated with the lipo-
polysaccharide fraction, 14 fall in this group. Extensive long-standing
disease in one or both lungs has not shown striking changes in serial
x-ray films. Clinical symptoms, however, diminshed, sputum decreased,
and the process did not advance.
Dosageandtoxicity
The patients in this series have been given subcutaneous injections
at bi-weekly intervals for aperiod of six months. This has been followed
by weekly injections for another six months or longer if the case was
not stable or the closure of the cavity incomplete. The initial injection
has been 1/40 cc. of the saline suspension of the complex containing
1 mg. per cc., and the amount has been increased as rapidly as possible,
controlled by the extent of the local reaction.
A repetition of many of the smaller doses has been necessary in
the more acute cases. Those with more stable lesions tolerated a
steadily risingscale, except where an occasional vigorous local effect has
unexpectedly appeared. The maximum amount given up to the present
in asingledosehasbeen 0.5 cc. Thishasnotbeenexceeded on accountof
the induration produced at the point of injection, but it has been re-
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peated many times often with no marked inflammatory reaction but
with the constant production of areas of thickening in the subcutaneous
tissue.
Localreactions
The local reaction which has followed the subcutaneous injection
has been used as a guide in the use of the lipo-polysaccharide prepara-
tion. In 18 to 24 hours an area of erythema has appeared varying in
size from 2 to 10 cm., accompanied with heat and induration. In 48
hours theredness hasdisappeared leaving afirm local injection point. Its
absorption varied, often lasting a week. Occasionally subsequent in-
jections gave rise to an Arthus' phenomenon. As the duration of the
treatment increased, the local reaction has become less marked and, with
increasing doses, often failed to appear even when full amounts were
injected.
In the first preparation used, the lipid content was sufficiently con-
centrated to cause such a marked local reaction that in three patients the
area broke down and yielded a serous secretion for from two days to
four weeks. Healing then took place leaving an indurated scar. These
reactions led to amodification of the lipid content. In the past year only
one such injection site softened and discharged.
Generalreactions
The absence of tuberculo-protein in the fraction, as proven chemi-
cally and by experimental use, led us to believe that little if any general
reactionwouldoccur. Whilethiswastrue in the largemajorityoftreated
cases a few have been seen. In four individuals having extensive active
lesions, following the first or second inoculation (1/40 or 1/20 cc.)
within 24 hours there was a sharp rise in temperature, accompanied
by chilliness, malaise, and slight nausea. At the end of 36 hours all of
the symptoms disappeared and the patient felt little the worse for the
experience. The local reaction inthesecaseswasverymarked atthistime.
No increase ofpulmonary symptoms, such as chest pain, hemoptysis, or
increased sputum, occurred.
On several occasions following 8 to 12 weeks of treatment a
general reaction has occurred in a few patients. Temperature rose to
99.2 to 1020 and lasted from one to two days without any lasting
detrimental effects. The reason for this irregular recurrence of these
symptoms is not yet clear. When they have appeared and reappeared, a
cautious advance in dosage of the fraction has been carried out.
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Comment
The natural reaction of the phthisiologist to any new or partly tried
methodoftreatingtuberculosis is thatofextreme skepticism. Spectacular
results from bed rest alone are not infrequent, especially in the short-
lived exudative lesion. Controlled observations are therefore desirable,
but in a disease of so great diversity of form difficult of attainment.
The solution may lie in a selection of only the grave case for
treatment, or in instituting treatment only after the failure of a sub-
stantial period of sanatorium care.
In the present series, one or both of these conditions pertain and
on this account some optimism is justified at the recorded results. The
possibilities of the use of combined fractions of the tubercle bacillus
in the treatment of phthisis, either with more potent products or
possibly with type-specific carbohydrate are an unexplored field. They
offer promise of therapeutic results used alone or in conjunction with
some antibiotic.
Summary
A lipo-polysaccharide fraction of the tubercle bacillus has been
found to have some therapeutic value in the treatment of pulmonary
tuberculosis. The clinical results are more suggestive because of the
severity of the type of case treated. The possibilities of this line of treat-
ment justify further investigation.
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CASE 1: J. A. D., male, aged 40 years. Rightsided thorocoplasty 1939; cavity developed in the
upper left lung in 1940. No change of cavity in nearly 5 )ears of sanatorium treatment. Use of fraction
for I I,' years. Cavity now closed:, sputum reverted from being constantlh positive to negative.FEB. 1945 SEPT. 1945
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CASE 2: L. B., female, aged 19 years. Sanatorium treatment for year 1942; relapse in 1944;
cavitation in both upper lobes. Use of fraction for 11,4 years. Cavities closed during this period and have
remained so. Sputum converted from positive to negative and remainied so for six months, then dis-
appeared. Well and working for about one year.
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CASE 3: S. P., male, aged 59 years. Disease advanced when first detected with bilateral upper lobe
cavitation. Treated with fraction for two years. Sputum reverted from positive to one consistently negative.
Cavities on the right closed; that on the left almost so after two years of inoculations.
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CASE 4: C. S., male, aged 24 years. Bad family history. Leftsided disease controlled by
pneumothorax. Employed for three years; relapse, with cavity in upper right lung. Fraction given
and cavity closed; has remained so for 1 /2 years. Well and working.